Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Biomea Fusion Announces First Patient Dosed in Phase I Study of BMF-650 a Next-Generation Oral GLP-1 Receptor Agonist
-
Navient Named Champion of Board Diversity by The Forum of Executive Women
-
Vitera Launches Institutional Share Class for State Street GTC Retirement Income Builder Target Date Fund Series, Expanding Guaranteed Income to More 401(k) Participants
-
Southern Realty Trust Commits $15.0 Million to a $45.0 Million Senior Bridge Loan for the Refinancing of a Premier Retail Property in Houston, TX
-
Sunrise Realty Trust Commits $30.0 Million to a $45.0 Million Senior Bridge Loan to Refinance a Premier Retail Property in Houston, TX
-
NodThera Announces First Patients Dosed in RESOLVE-2 Clinical Trial Evaluating Oral NT-0796 in Combination with a GLP-1 Receptor Agonist
-
Simbryo Technologies Introduces Personalized Assay to Help IVF Patients Avoid Repeated Failed Transfers
-
Vegas Golden Knights and Richtech Robotics Partner to Help Shape the Future of Sports and Technology
-
Amarin Issues Statement Supporting FDA’s Action to Revise Labeling for Fenofibrate Drugs Reinforcing a Lack of Cardiovascular Benefit
-
Centers for Medicare and Medicaid Services Assigns Permanent J Code for ZUSDURI™ Effective January 1, 2026
-
Pacira BioSciences Notified of Abbreviated New Drug Application Filing from Qilu Pharmaceutical (Hainan) Co., Ltd. for EXPAREL®
-
Elicio Therapeutics Reports Robust T cell Responses Across Diverse HLA backgrounds in Ongoing Phase 2 AMPLIFY-7P Trial
-
Glucose Health, Inc. Appoints Veteran Financial Executive Edmund “Ned” Burke to Its Board of Directors
-
Foremost Clean Energy Appoints Seasoned Mining Executive Peter Espig to Board of Directors
-
Registered Investment Advisors See Wire Fraud, AI Errors as Emerging Threats to their Business, According to Golsan Scruggs 2025 Risk Survey
-
AlphaTON (Nasdaq:ATON) and Cyncado Therapeutics: Preclinical Mesothelioma Data Show Direct A2B Tumor Activity; TT-4 Achieved >90% Tumor Growth Inhibition; First-Patient Dosing on Track for Q1 2026
-
WEBs Investments Announces Name Changes for Defined Volatility℠ ETFs
-
Verizon Expanding Broadband with New Strategic Fiber Agreement
-
Harvard-Stanford Study Features Byrna as the Exclusive Product Used to Measure Shift in Gun-Owner Attitudes Toward Non-Lethal Personal Defense
-
Aspida Life Insurance Company Launches RILA
-
Cocrystal Pharma Receives NIH SBIR Award to Advance its Influenza Inhibitor Program
-
Baylor University and Cordia Partner to Advance Sustainable Campus Energy Future
-
Bottomline Announces Embedded AI Agent to Transform Treasury and Cash Management
-
Access Softek Partners with Array to Deliver Embedded Credit, Identity, Privacy Tools and More in Digital Banking
-
Medera Announces First Patient Dosed in Phase 2 Portion of MUSIC-HFrEF Phase 1b/2 Trial Evaluating SRD-001 Gene Therapy for Heart Failure with Reduced Ejection Fraction
-
Synergy CHC Corp. (NASDAQ: SNYR) Announces FOCUSfactor® Named #1 Pharmacist Recommended OTC Memory Supplement for 2025-2026
-
Amneal Launches Brekiya® – the First and Only DHE Autoinjector for Adults with Migraine With or Without Aura and Cluster Headaches
-
TeleSpecialists Expands TeleEEG Service Line with Comprehensive Coverage Across All Study Types
-
Inspire Medical Systems, Inc. to Present at the 2025 UBS Global Healthcare Conference
-
Absci to Participate in Upcoming Investor Conferences
-
Greenridge Exploration Receives Airborne MobileMT Survey Results for the Sabre Uranium Project in Athabasca Basin, Saskatchewan
-
Esperion Announces New Analyses from CLEAR Outcomes to be Presented at the American Heart Association (AHA) Scientific Sessions 2025
-
Pave Bank raises $39 million to scale world’s first programmable bank built for digital assets and AI era
-
Schouw & Co. share buy-back programme, week 43 2025
-
Evaxion appoints Dr Helen Tayton-Martin as new Chief Executive Officer
-
Signify share repurchase period update
-
OXB to participate in upcoming investor conferences and events
-
Rectitude Holdings Partners with Pansik Technology Pte Ltd. to Drive Expansion in Renewable Energy Solutions
-
Rectitude Holdings Partners with Pansik Technology Pte Ltd. to Drive Expansion in Renewable Energy Solutions
-
KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia
-
Abstract’s Founder to Discuss How Real-World Experience Is Shaping the Path to AGI at Future Lawyer USA 2025
-
Sydbank A/S share buyback programme: transactions in week 43
-
BioNTech to Report Third Quarter 2025 Financial Results and Corporate Update on November 3, 2025
-
BexBack Launches Crypto Futures Trading with Up to 100x Leverage, No KYC Access and $100 Welcome Bonus
-
Form 8.3 - Avadel Pharmaceuticals plc
-
LIFE AI Joins First Ever FastTrack AI Accelerator Powered By GenAI Fund and NVIDIA Inception Program
-
Abaxx Exchange Integrates with TradingView, Extending LNG and Singapore Gold Futures Contract Liquidity to 100M+ Users
-
Blaqclouds Executes Blockchain Partnership with Super Studios USA, Led by Former Ridley Scott & Associates Executive Producer Developing a Billion-Dollar Entertainment Complex in Texas
-
Intellia Therapeutics Provides Update on MAGNITUDE Clinical Trials of Nexiguran Ziclumeran (nex-z)
-
BrainsWay Announces Additional Minority-Stake Investments in Leading U.S. Mental Health Providers
